Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors-Reference-Cited by-同舟云学术

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors

Published:2005 Issue:4 Volume:104 Page:841-847
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Marina Neyssa,Chang Kay W.,Malogolowkin Marcio,London Wendy B.,Frazier A. Lindsay,Womer Richard B.,Rescorla Frederick,Billmire Deborah F.,Davis Mary M.,Perlman Elizabeth J.,Giller Roger,Lauer Stephen J.,Olson Thomas A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Teratomas in childhood: Analysis of 142 cases

2. Embryonal adenocarcinomas (a type of malignant teratoma) of the sacrococcygeal region.Clinical and pathologic aspects of 21 cases

3. Endodermal sinus tumor of the ovary.A clinical and pathologic analysis of 71 cases

4. Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin and ototoxicity in childhood: the perspective of supporting otoprotective agentes;Brazilian Journal of Biology;2024

2. Acute and Long-Term Side Effects of Radiation Therapy in Pediatric Cancer Treatment;Pediatric Surgical Oncology;2023

3. Gonadal and Extragonadal Germ Cell Tumors, Sex Cord Stromal and Rare Gonadal Tumors;Pediatric Oncology;2022

4. The global hearing therapeutic pipeline: 2021;Drug Discovery Today;2021-11

5. Update on pediatric testicular germ cell tumors;Journal of Pediatric Surgery;2021-04